ATLANTA, GA — The Centers for Disease Control and Prevention released new data on March 5 showing fentanyl remained the most frequently cited drug in U.S. overdose deaths from 2017 through 2023, while methamphetamine surged to second place and previously prominent substances like heroin dropped sharply in rankings, according to the National Center for Health Statistics report.
The analysis examined literal text documentation on death certificates over the seven-year period, providing more detailed insights than monthly provisional statistics, according to the CDC. Total drug overdose deaths climbed nearly 54% during this timeframe, rising from 70,715 deaths in 2017 to a peak of 108,790 in 2022, before declining slightly to 106,352 in 2023, as reported by federal health officials.
Fentanyl-involved deaths increased from 27,542 in 2017 to 73,944 in 2022, then decreased slightly in 2023, according to the CDC data. The synthetic opioid appeared in approximately 68.9% of overdose death certificates by 2023, compared to 38.9% in 2017, as reported by Filter Magazine's analysis of the federal data. In unintentional overdose deaths specifically, fentanyl was cited in 71.9% of cases in 2023, according to the NCHS report.
Methamphetamine-involved fatalities more than tripled during the study period, climbing from 9,438 deaths in 2017 to 34,167 in 2023, moving the stimulant from fourth to second place in rankings, according to CDC officials. Cocaine remained consistently among the top three substances, with deaths more than doubling from 15,050 in 2017 to 31,700 in 2023, as reported in the federal analysis.
Shifting Substance Patterns
Heroin showed the most dramatic decline of any tracked substance, dropping from the second most commonly cited drug in 2017 to seventh place by 2023, according to the CDC report. This shift reflects changing patterns in the illicit drug supply as synthetic opioids have largely displaced heroin in many markets, according to substance abuse researchers.
New substances emerged on the rankings during the study period. Xylazine, a veterinary sedative, first appeared among the 15 most frequently cited drugs in 2021 and climbed to fourth place by 2023, according to federal health officials. Bromazolam, an unregulated benzodiazepine, jumped from fewer than 10 documented cases in 2020 to 1,734 cases in 2023, replacing diazepam on the top-15 list, as reported by Filter Magazine.
Gabapentin, a prescription medication approved for seizures and nerve pain, surged from 13th to 7th place during the study period, according to the CDC data. Alprazolam, a prescription benzodiazepine, remained consistently in fifth place throughout the seven years, as reported in the federal analysis.
The report analyzed death certificate data collected through the National Vital Statistics System, using ICD-10 coding to identify specific substances, according to CDC methodology. Approximately 96% of overdose deaths in 2023 included specific drug citations, compared to 75% in 2011, reflecting improved documentation practices, as reported by Filter Magazine.
Intent Classification Patterns
Among deaths classified as unintentional in 2023, fentanyl led citations at 71.9%, followed by methamphetamine at 33.9% and cocaine at 31.0%, according to the NCHS report. For deaths classified as suicides, fentanyl was also most frequently cited, with diphenhydramine and oxycodone appearing prominently, as reported by federal officials.
Federal regulations require medical examiners and coroners to document substances found during death investigations, though testing protocols and reporting practices vary by jurisdiction. The literal text approach captures drug names exactly as written on death certificates, providing more granular detail than broad category classifications like "synthetic opioids other than methadone," according to CDC methodology.
Long-Term Care Implications
While the CDC report covers general population trends, substance misuse and medication management remain critical safety issues in nursing homes and assisted living facilities. Federal regulations require long-term care facilities to prevent medication errors and monitor residents for signs of substance misuse or diversion.
Medications frequently cited in overdose deaths, including opioids, benzodiazepines, and gabapentin, are commonly prescribed in nursing homes for pain management, anxiety, and neuropathic conditions. The Centers for Medicare and Medicaid Services requires facilities to implement medication storage, administration, and monitoring protocols to prevent adverse events.
Family members concerned about medication safety in long-term care settings should ask facilities about their medication management policies, pharmacy oversight procedures, and staff training on substance diversion prevention, according to patient advocacy organizations.
Resources for Families
The National Long-Term Care Ombudsman Resource Center provides free assistance to families with concerns about care quality in nursing homes and assisted living facilities. The national hotline can be reached at 1-800-677-1116, and additional resources are available at https://ltcombudsman.org.
Families who suspect medication errors, diversion, or other safety concerns should report issues to their state ombudsman program and the state health department. The Substance Abuse and Mental Health Services Administration operates a national helpline at 1-800-662-4357 for families seeking information about substance use disorders and treatment resources.
💬 Join the Discussion
Comments are moderated. Please keep discussions respectful and relevant to nursing home care quality.